Compare Enbridge Inc (ENB) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Illumina, Inc. — how do they compare? Enbridge Inc trades at $51.97 (market cap $112.62B), while Illumina, Inc. trades at $193.06 (market cap $29.12B). The key difference: Enbridge Inc is far larger — about 3.9× Illumina, Inc.'s market cap, and Enbridge Inc pays a 5.34% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ENB | ILMN | |
|---|---|---|
Market Cap | $112.62B | $29.12B |
Sector | Energy | Health |
52-Week High | $58.04 | $205.10 |
52-Week Low | $45.23 | $91.00 |
Enterprise Value | $196.53B | $30.48B |
Dividend Yield | 5.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
